Early warning for schizophrenia found in spinal fluid

The study, published today in PLoS Medicine, shows that newly diagnosed schizophrenic patients have higher levels of glucose in their brain and spinal fluid than healthy individuals. Scientists hope these findings could be used for early diagnosis and treatment of the condition and could help them to develop more effective drugs.

There is currently no diagnostic test for schizophrenia, which affects around one in every 100 people. Diagnosis of the condition through clinical interviews and patient observations can be difficult and time-consuming, due to its wide range of symptoms and its similarity to other mental disorders.

The team from Imperial College London, the University of Cambridge and the University of Cologne analysed cerebrospinal fluid (CSF) from 152 volunteers. 54 of these had recently been diagnosed with schizophrenia, 70 were healthy volunteers with no schizophrenia, while 28 were receiving some form of treatment.

They found there were alterations in the way the body metabolised glucose in the 54 volunteers who had recently been diagnosed with schizophrenia but had not received any treatment, when compared with the group without schizophrenia.

In the group receiving one type of drug therapy, there were marked improvements in the glucose levels when they were treated after their first psychotic episode, underlining the importance of early detection and treatment.

Glucose is the main energy source for our bodies but evidence from this and other studies suggests that those with schizophrenia use a different energy source in their brains, called lactate. This means that glucose levels remain high in the brain because the glucose is not being used effectively.

Dr Tsz Tsang , one of the researchers on the study from Imperial College London, said: "We were surprised to find such apparent chemical imbalances in the spinal fluids of people with a psychiatric disorder. The research highlights the potential of metabolic profiling as a powerful diagnostic tool for neurological disorders.

"Our preliminary findings here provide further insight into the pathological mechanisms that are occurring. Determining the presence of these 'biomarkers' in fluids that are more easily accessible, such as blood or urine, may provide a more convenient platform for diagnosing neuropsychiatric conditions in the future," said Dr Tsang.

Dr Tsang's colleague, Dr Elaine Holmes , added: "This research could be of huge importance in how we deal with schizophrenia. It shows we can now spot the changes which occur before it becomes a major problem."

Source: Imperial College London

Related stories:

Patterns of normal brain activity may predispose individuals to different symptoms of psychosis
A new study released today offers a potential predictive technique to anticipate how individuals might behave during a psychotic episode. The study, in the June 18 issue of The Journal of Neuroscience, related the brain activity of healthy participants to how they behaved after exposure to ketamine (a psychosis-inducing drug that mimics schizophrenia symptoms). The findings help explain why schizophrenia symptoms vary greatly from person to person and may ultimately help personalize diagnosis and intervention.
Siblings of schizophrenia patients display subtle shape abnormalities in brain
Subtle malformations in the brains of patients with schizophrenia also tend to occur in their healthy siblings, according to investigators at the Silvio Conte Center for the Neuroscience of Mental Disorders at Washington University School of Medicine in St. Louis. Shape abnormalities were found in the brain's thalamus.
Researchers discover possible markers for mental illness
Researchers have discovered natural genetic differences that might help predict the most effective antipsychotic drugs for particular patients with mental disorders such as schizophrenia, Parkinson’s and drug addiction.
Insulin's brain impact links drugs and diabetes
Insulin, long known as an important regulator of blood glucose levels, now has a newly appreciated role in the brain.
Genes May Hold Keys to How Humans Learn
New research is giving scientists fresh insights into how genetics are a prime factor in how we learn.
Schizophrenia candidate genes affect even healthy individuals
Do gene variants that convey risk for schizophrenia affect apparently healthy individuals? Although these genes are present in every human, individuals may have different versions of these genes, called alleles. While many people who possess these “risk alleles” do not end up with schizophrenia, this does not mean they are unaffected by the presence of the risk allele.
60 second test could help early diagnosis of common brain diseases
Until recently physicians have had to rely on time-consuming and uncertain behavioural examinations to diagnose the onset of brain diseases such as multiple sclerosis, Alzheimer's and schizophrenia.
For Better Understanding, Researcher Simulates Schizophrenia in Healthy People
To better understand schizophrenia, a University of Missouri-Columbia psychology researcher simulated one of its more common symptoms - the inability to speak clearly or respond to questions in a precise manner - in people who don't have the illness.

News discussion:

Medicine & Health news